IRadimed Corporation (IRMD) Financials
IRMD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 115.0 million | 13.2 million |
| March 31, 2026 | 114.4 million | 15.9 million |
| Dec. 31, 2025 | 108.8 million | 14.2 million |
| Sept. 30, 2025 | 114.7 million | 16.4 million |
IRMD Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 5.8 million | 807000 |
| March 31, 2026 | 7.9 million | 684000 |
| Dec. 31, 2025 | 5.4 million | 696236 |
| Sept. 30, 2025 | 5.8 million | 666082 |
IRMD Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | 5.2 million |
| March 31, 2026 | 5.8 million |
| Dec. 31, 2025 | 6.4 million |
| Sept. 30, 2025 | 5.6 million |
IRMD Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 59.1 million | - | - |
| March 31, 2026 | 56.4 million | - | - |
| Dec. 31, 2025 | 51.2 million | - | - |
| Sept. 30, 2025 | 56.5 million | - | - |
IRMD Shares Outstanding
IRMD Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 185000 | 657000 | 8.1 million | 4.2 million |
| March 31, 2026 | 403000 | 956000 | 8.6 million | 4.1 million |
| Dec. 31, 2025 | 482166 | 799000 | 9.1 million | 4.6 million |
| Sept. 30, 2025 | 1.1 million | 674362 | 9.0 million | 4.6 million |
IRMD Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 20.5 million | 5.3 million |
| March 31, 2026 | 22.0 million | 5.2 million |
| Dec. 31, 2025 | 22.7 million | 5.7 million |
| Sept. 30, 2025 | 21.2 million | 4.7 million |
IRMD Revenue by Segment
IRMD
Price: $87.45
Dividend Yield: 1.47%
Forward Dividend Yield: 0.93%
Payout Ratio: 41.10%
Dividend Per Share: 0.80 USD
Earnings Per Share: 1.79 USD
P/E Ratio: 51.32
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 20987
Ebitda: 1.3 millionMarket Capitalization: 1.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 4